1190890-96-0

Basic information

• Product Name: (2-(4-tolyl)ethyl)carbamic acid tert-butyl ester
• Synonyms: (2-(4-tolyl)ethyl)carbamic acid tert-butyl ester
• CAS NO: 1190890-96-0
• Molecular Weight: 235.326
• Mol File: 1190890-96-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 355.3±21.0 °C(Predicted)
• Density: 1.008±0.06 g/cm3(Predicted)
• CAS DataBase Reference: (2-(4-tolyl)ethyl)carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2-(4-tolyl)ethyl)carbamic acid tert-butyl ester(1190890-96-0)
• EPA Substance Registry System: (2-(4-tolyl)ethyl)carbamic acid tert-butyl ester(1190890-96-0)

Safety Data

• Hazardous Substances Data: 1190890-96-0(Hazardous Substances Data)

Usage

Description

(2-(4-tolyl)ethyl)carbamic acid tert-butyl ester is an ester formed from the reaction of (2-(4-tolyl)ethyl)carbamic acid and tert-butanol. It is a chemical compound commonly used as a starting material in the synthesis of various pharmaceuticals and agrochemicals.

Uses

Used in Pharmaceutical Industry:
(2-(4-tolyl)ethyl)carbamic acid tert-butyl ester is used as a starting material for the synthesis of various pharmaceuticals. Its stability and ease of handling make it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
(2-(4-tolyl)ethyl)carbamic acid tert-butyl ester has potential applications as a pesticide, herbicide, or fungicide. Its use in these areas can contribute to the development of more effective and safer agricultural products.
Used in Organic Synthesis:
(2-(4-tolyl)ethyl)carbamic acid tert-butyl ester is used as a reagent in organic synthesis, particularly in the production of new compounds for pharmaceutical research. Its versatility and stability make it a valuable tool in the synthesis of complex organic molecules.

Upstream product

• 3261-62-9 2-(p-tolyl)ethylamine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1279558-78-9 2-(4-(fluoromethyl)phenyl)ethylamine 
• 914103-95-0 [2-(4-(bromomethyl)phenyl)ethyl]carbamic acid tert-butyl ester 
• 1427565-74-9 C₁₅H₂₃NO₂ 
• 229621-74-3 N-methyl-2-(p-tolyl)ethan-1-amine 

Relevant articles and documents

Catalytic Strategy for Regioselective Arylethylamine Synthesis

A mild, modular, and practical catalytic system for the synthesis of the highly privileged phenethylamine pharmacophore is reported. Using a unique combination of organic catalysts to promote the transfer of electrons and hydrogen atoms, this system performs direct hydroarylation of vinyl amine derivatives with a wide range of aryl halides (including aryl chlorides). This general and highly chemoselective protocol delivers a broad range of arylethylamine products with complete regiocontrol. The utility of this process is highlighted by its scalability and the modular synthesis of an array of bioactive small molecules.

NOVEL NON-SYSTEMIC TGR5 AGONISTS

The present invention relates to tricyclic compounds of formula (I) and formula (II), or a pharmaceutically acceptable salt thereof. The present tricyclic compounds are useful non-sytemic TGR5 agonists that can be used to treat diabetic diseases in human. The present invention provides a pharmaceutical composition containing tricyclic compounds of formula (I) and formula (II) and a method of making as well as a method of using same in treating patients inflicted with metabolic disorders by administering same. The compounds of the present invention may be used in combination with additional anti-diabetic drugs.

THERAPEUTIC AGENT FOR CEREBRAL INFARCTION

The invention provides a therapeutic drug for ischemic stroke. The therapeutic drug has the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof, as an active ingredient.